In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq

Fatima Alzubaidi; Rafal Jalil Al-Saigh; Enass  Oubaid; Charis  Liapi; Hussam Al-humadi

doi:10.47750/pnr.2022.13.02.018

2022, Vol: 13, Issue: 2

13/2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Original Article

PNR. 2022; 13(2): 113-118

doi: 10.47750/pnr.2022.13.02.018

In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq

Fatima Alzubaidi, Rafal Jalil Al-Saigh, Enass Oubaid, Charis Liapi, Hussam Al-humadi.

Abstract
Background: Bioequivalence and bioavailability of antimicrobial drugs are considered as a critical issue in treatment of infectious diseases. Recently, some variations have been detected in clinical response to some antimicrobial agents. Ciprofloxacin is one of broad spectrum bactericidal agent that has been used widely in community which motivate us to assess its quality and quantity within available brands. Methods: Ciprofloxacin tablets from brand company (A) and other generic companies (B, C and D) have been selected, a standard powder in specific amount was dissolved and injected directly into HPLC to interpolate with the quantity of ciprofloxacin from each company tablet. In vitro dissolution rate was evaluated for all by calculating the difference and similarity factors. Antimicrobial effect was evaluated by minimum inhibitory concentration (MIC) method for reference strains of low to high level quinolone resistant bacteria. Results: Ciprofloxacin content was approved within accepted range for all companies except D that exceed the rang value. The dissolution testing was very rapid for A and B (>85%) within 15 minutes, while for D was <80% during first 30 minutes. MIC for 24 hours of 0.128-500mg/L ciprofloxacin for all strains showed better results seen in A and B than D. Conclusion: ciprofloxacin tablet of A, B and C companies were approved under the light of the quality test and antibacterial efficacy in comparison with D company, that urge for continuous monitoring and evaluation to avoid drug usefulness and resistance.

Key words: Quality Assessment, Antibacterial Activity, Ciprofloxacin, Dissolution Rate, MIC, Quality Control

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Fatima Alzubaidi Articles by Rafal Jalil Al-Saigh Articles by Enass Oubaid Articles by Charis Liapi Articles by Hussam Al-humadi
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Alzubaidi F, Al-Saigh RJ, Oubaid E, Liapi C, Al-humadi H, . In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq. PNR. 2022; 13(2): 113-118. doi:10.47750/pnr.2022.13.02.018

Web Style

Alzubaidi F, Al-Saigh RJ, Oubaid E, Liapi C, Al-humadi H, . In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq. https://www.pnrjournal.com/?mno=99658 [Access: August 11, 2022]. doi:10.47750/pnr.2022.13.02.018

AMA (American Medical Association) Style

Alzubaidi F, Al-Saigh RJ, Oubaid E, Liapi C, Al-humadi H, . In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq. PNR. 2022; 13(2): 113-118. doi:10.47750/pnr.2022.13.02.018

Vancouver/ICMJE Style

Alzubaidi F, Al-Saigh RJ, Oubaid E, Liapi C, Al-humadi H, . In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq. PNR. (2022), [cited August 11, 2022]; 13(2): 113-118. doi:10.47750/pnr.2022.13.02.018

Harvard Style

Alzubaidi, F., Al-Saigh, R. J., Oubaid, E., Liapi, C., Al-humadi, H. & (2022) In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq. PNR, 13 (2), 113-118. doi:10.47750/pnr.2022.13.02.018

Turabian Style

Alzubaidi, Fatima, Rafal Jalil Al-Saigh, Enass Oubaid, Charis Liapi, Hussam Al-humadi, and . 2022. In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq. Journal of Pharmaceutical Negative Results, 13 (2), 113-118. doi:10.47750/pnr.2022.13.02.018

Chicago Style

Alzubaidi, Fatima, Rafal Jalil Al-Saigh, Enass Oubaid, Charis Liapi, Hussam Al-humadi, and . "In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq." Journal of Pharmaceutical Negative Results 13 (2022), 113-118. doi:10.47750/pnr.2022.13.02.018

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Alzubaidi, F., Al-Saigh, R. J., Oubaid, E., Liapi, C., Al-humadi, H. & (2022) In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq. Journal of Pharmaceutical Negative Results, 13 (2), 113-118. doi:10.47750/pnr.2022.13.02.018

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Journal of Pharmaceutical Negative Results are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Copyright � 2022 Journal of Pharmaceutical Negative Results All Rights Reserved. Subject to change without notice from or liability to Journal of Pharmaceutical Negative Results. For best results, please use Internet Explorer or Google Chrome	Contact Information ResearchTrentz Scientific Research Community Contact US 21, First Floor,ResearchTrentz (Registred Office) Thamotharan Street,India Email : editorial@pnrjournal.com, Support : pnrjournal@gmail.com

Contact Information

How to cite this article